Else Nutrition - CEO, Hamutal Yitzhak.
CEO, Hamutal Yitzhak.
Source: Else Nutrition.
  • Else (BABY) has produced the first whole-plant soy-free infant formula in advance of FDA approval
  • Initial production will be tested for safety and to validate nutritional benefits
  • The company expects its infant formula to become its flagship product
  • Else Nutrition is an Israel-based food and nutrition company
  • Else (BABY) is up by 3.7 per cent trading at $1.40 per share

Else (BABY) has produced the first whole-plant soy-free infant formula in advance of FDA approval.

The patent-protected formula was developed to meet Clean Label Certification guidelines and global regulations and clinical requirements for infant nutrition.

Initial commercial production, completed last month, will be used in key clinical studies for the U.S. market to validate product safety and benefits for regulatory approval.

The company anticipates its infant formula to grow into its flagship product.

Else Nutrition is an Israel-based food and nutrition company

Else (BABY) is up by 3.7 per cent trading at $1.40 per share as of 9:37 am EST.

More From The Market Online

Tilray’s Breckenridge Brewery honours Denver Nuggets with new ale

Tilray Brands (TSX:TLRY) subsidiary Breckenridge Brewery launches a new ale to recognize the 2023 NBA championship-winning Denver Nuggets.

GameStop stock struggles on weak Q4 2023 performance

GameStop Corp. (NYSE:GME) stock struggles after reporting weak Q4 2023 financial results, but it eventually claws back some gains.

BlackBerry opens Cybersecurity Centre of Excellence in Malaysia

BlackBerry (TSX:BB) opens its Cybersecurity Centre of Excellence in Malaysia to deliver cybersecurity training and cyber threat intelligence.